Cardiometabolic multimorbidity (CMM) was one of the most common comorbidity aggregation patterns in different regions and populations, with a high risk of mortality. However, studies on the clinical and medication characteristics of CMM were limited.

To study the clinical characteristics and medication patterns of patients with CMM in the real world, and provide reference basis for the prevention and management of CMM.

Outpatient patients who were diagnosed with CMM in the hospital information system (HIS) of the First Affiliated Hospital of Ningbo University from January 2023 to June 2023 were selected. Basic prescription information was collected and analyzed using frequency analysis and association rule analysis methods.

A total of 7 059 patients with CMM were included, of which 3 960 (56.1%) were male and 3 099 (43.9%) were female, with an age range of 18 to 97 years and a mean age of (58.1±13.7) years. The results showed that 3 910 patients with less than 5 types of medication, accounting for 55.4%; 2 740 patients with 5-9 types of medication, accounting for 38.8%; and 409 patients with more than 10 types of medication, accounting for 5.8%. Hypertension, dyslipidemia, and diabetes were the core diseases of CMM. Among the comorbidities of cardiovascular metabolic diseases, chronic gastritis, renal insufficiency, and hyperuricemia were more common. In the prescription of patients with CMM, statins, calcium channel blockers (CCB), angiotensin receptor blockers (ARB), metformin, and sodium-dependent glucose transporters 2 inhibitors (SGLT2i) were the core medications.

Our findings suggest chronic gastritis, renal insufficiency, and hyperuricemia are more common diseases in patients with CMM. Screening and prevention should be strengthened and treatment strategies should be adjusted. In the CMM drug prescription, lipid-lowering, antihypertensive, and hypoglycemic drugs are the core drugs used.

心血管代谢性共病（CMM）是不同地区和人群中主要的共病聚集模式之一，具有较高的死亡风险，目前有关CMM患者的临床特征及用药特点的研究较少。

研究真实世界中CMM患者的临床特征及用药规律，为CMM的预防和管理提供参考依据。

基于回顾性研究的方法，选取宁波大学附属第一医院2023年1—6月医院信息系统中诊断为CMM的门诊患者为研究对象，采集其疾病诊断与处方基本信息，使用频数分析和关联规则分析方法进行分析。

本研究共纳入7 059例CMM患者，其中男性患者3 960例（56.1%），女性患者3 099例（43.9%）；年龄18~97岁，平均年龄（58.1±13.7）岁。患者用药品种数<5种的3 910例次（占55.4%），用药品种数5~9种的2 740例次（占38.8%），用药品种数≥10种的409例次（占5.8%）。高血压、血脂异常和糖尿病是CMM的核心疾病，除此之外，又以慢性胃炎、肾功能不全以及高尿酸血症等疾病较常见。CMM药物处方中，以他汀类药物、钙通道阻滞剂（CCB）、血管紧张素Ⅱ受体拮抗剂（ARB）、二甲双胍、钠-葡萄糖共转运蛋白2抑制剂（SGLT2i）为核心用药。

CMM患者中慢性胃炎、肾功能不全以及高尿酸血症等疾病较常见，应加强对其筛查和预防。CMM药物处方中，以降脂、降压、降糖药物为核心用药。